Cardiac Surgery With Cardiopulmonary Bypass, Complete Serum Creatinine Measure, Complete Serum Phosphorus Measure
Conditions
Keywords
acute kidney injury, cardiac surgery, cardiac surgery associated acute kidney injury, renal replacement therapy, renal recovery, serum hyperphosphatemia
Brief summary
Cardiac surgery associated acute kidney injury is an independent factor of morbidity and mortality . Despite its delayed elevation, serum creatinine (Cr) remains the goal standard to diagnose AKI. Hyperphosphatemia is well-know in case of AKI because of its excretion decrease. Moreover, serum phosphorus (Ph) is daily measure d after cardiac surgery since its variation may lead to cardiac dysfunction. In case of AKI, Ph may reflect the decrease of renal function in this context. Consequently, the purpose of this study is to evaluate the predictibility of Ph to detect both AKI induction and in a second time, renal recovery.
Detailed description
It is a one-year prospective diagnostic validation study included all patients \> 18 years-odl admitted in our center after cardiac surgery. AKI is define according to KDIGO criteria and classified in the groups of severity according to the Cr elevation and the need of renal replacement therapy. Serum Cr and Ph are measured at baseline before surgery , at ICU admission, every 12 hours until ICU discharge and every 24 hours until hospital discharge. To evaluate the predictability of Of Ph to diagnose AKI, the postoperative Ph percentage of maximal elevation (%EPh) will be calculated. Then the diagnostic performance of %EPh wil be assessed by calculating the areas under the Receiver Operating Characteristic Curve (AUC) to determine an optimal threshold with sensibility, specificity, positive predictive value and negative predictive value.
Interventions
OTHERcardiac surgery
Cohort of patients who are more than 18 years having cardiac surgery and having benefited from a dosage of serum phosphorus level and serum creatinine during all the duration of the hospitalisation
Sponsors
University Hospital, Montpellier
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* All the patients who are more than 18 years having cardiac surgery and having benefited from a dosage of serum phosphorus level and serum creatinine during all the duration of the hospitalisation
Exclusion criteria
* Chronic renal insufficiency with a glomerular filtration rate = 15ml / min / 1.73m2 * Chronic Renal insufficiency dialysed * History of single kidney or nephrectomy * Vulnerable people according to the article L1121-6 of the public health Code * Protected adult or in the incapacity to give his consent according to the article L1121-8 of the public health Code * The patient present formalizes his opposition for the continuation of the study * Pregnant or breast-feeding Women according to the article L1121-5 of the Public health Code
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Dosage of phosphorus | 48 hour after cardiac surgery | Kinetic phosphorus during acute renal failure in postoperative cardiac surgery |
Countries
France
Outcome results
None listed